Quick Takeaways
- David Norman Cade has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,794,766.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David Norman Cade
- Location
- North Melbourne
- Summary
- The estimated net worth of David Norman Cade is at least $2,794,766 dollars as of 01 Apr 2026. David Norman Cade is the Group Chief Medical Officer of Telix Pharmaceuticals Ltd and owns shares of Telix Pharmaceuticals Ltd (TLX) stock worth about $2.79M.
- Signature
- /s/ Oliver Newman, on behalf of Dr. David Cade, Group CMO
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David Norman Cade and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Telix Pharmaceuticals Ltd ($2,794,766).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David Norman Cade
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TLX, TLPPF | Telix Pharmaceuticals Ltd | Group Chief Medical Officer | $2,794,766 | 18 Mar 2026 |
Insider Transactions Reported by David Norman Cade:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.